Table 3.
Survival analyses of prognostic factors in ENKTL
| Variable | p value |
|---|---|
| Gender |
|
| Male versus Female |
0.0658 |
| Age (years) |
|
| ≤40y versus >40y |
0.8679 |
| Ann Arbor Stage |
|
| Stage I, II versus Stage III, IV |
0.4129 |
| LDH level |
|
| High versus Normal |
0.7703 |
| B symptoms |
|
| Positive versus Negative |
0.0180* |
| IPI |
|
| L/LI versus HI/H |
0.5418 |
| Treatment |
|
| Single therapy versus Combined therapy |
0.0082* |
| LMP1 expression |
|
| Positive versus Negative |
0.0201* |
| LMP2A expression |
|
| Positive versus Negative | 0.0487* |
LDH: lactate dehydrogenase; IPI: international prognostic index.
L: low risk; LI: low-intermiediate risk; HI: high-intermiediate risk.
* P < 0.05.